Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
0.9001
-0.0799 (-8.15%)
At close: Feb 4, 2026, 4:00 PM EST
0.8821
-0.0180 (-2.00%)
Pre-market: Feb 5, 2026, 8:30 AM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021
Period Ending
Dec '23 Dec '22 Dec '21
Next-generation Cell and Gene Therapies
2.56M
Next-generation Cell and Gene Therapies Growth
-40.25%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021
Period Ending
Dec '23 Dec '22 Dec '21
United States
2.56M
United States Growth
-40.25%